PROTEAS BIOANALYTICS INC

Proteas Bioanalytics Inc., develops innovative proteomics platforms to detect human diseases at their earliest stage, before the onset of symptoms, from a single drop of blood. Our advanced technologies will also provide objective guidance regarding treatment options and efficacy. We intend to dramatically reshape early diagnosis and treatment across multiple diseases.Business: We are both a platform and disease-specific biosignature assay development and implementation company. Our core bioanalysis technology can be partnered across indications to pharma and biotech companies, while our internal biomarker platforms will be developed for high unmet needs in the clinical arena.